New RA meds better than old, study finds
The latest class of drugs used to treat rheumatoid arthritis (RA) are more effective at treating the condition than older standard treatments, new research suggests. Spanish researchers looked at 13 studies that involved RA patients' use of newer tumour necrosis factor alpha (TNFa) blocking drugs such as Enbrel, Remicade, and Humira. They found that the anti-TNFa drugs were better than the usual treatments, such as methotrexate, for treating RA. The researchers also found that patients who hadn't responded to methotrexate alone showed a better response with combined anti-TNFα plus methotrexate therapy.
(Medical News Today) UPDATED 04/17/2008Click here to read the full story

